综述

黄色肉芽肿性胆囊炎的诊治

展开
  • 上海中医药大学附属普陀医院微创外科,上海 200333

收稿日期: 2020-02-24

  网络出版日期: 2022-08-03

基金资助

上海市普陀区临床特色专病建设项目(2020tszb03);上海市医学重点专科建设项目(ZK2019B18)

Diagnosis and treatment of xanthogranulomatous cholecystitis

Expand

Received date: 2020-02-24

  Online published: 2022-08-03

本文引用格式

吴文韬, 李炜, 曹亦军 . 黄色肉芽肿性胆囊炎的诊治[J]. 外科理论与实践, 2021 , 26(03) : 271 -274 . DOI: 10.16139/j.1007-9610.2021.03.020

参考文献

[1] Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. report of 180 cases[J]. Arch Pathol, 1970, 90(5):423-432.
[2] McCoy JJ Jr, Vila R, Petrossian G, et al. Xanthogranulomatous cholecystitis. report of two cases[J]. J S C Med Assoc, 1976, 72(3):78-79.
[3] Guzmán-Valdivia G. Xanthogranulomatous cholecystitis: 15 years′ experience[J]. World J Surg, 2004, 28(3):254-257.
[4] 张弢, 王明亮, 臧潞, 等. 黄色肉芽肿性胆囊炎74例诊治分析[J]. 中国实用外科杂志, 2007, 27(7):549-550.
[5] Yucel O, Uzun MA, Tilki M, et al. Xanthogranulomatous cholecystitis: analysis of 108 patients[J]. Indian J Surg, 2017, 79(6):510-514.
[6] Ewelukwa O, Ali O, Akram S. Xanthogranulomatous cholecystitis mimicking gallbladder cancer[J]. BMJ Case Rep, 2014:bcr2013200530.
[7] Hale MD, Roberts KJ, Hodson J, et al. Xanthogranulomatous cholecystitis: a European and global perspective[J]. HPB (Oxford), 2014, 16(5):448-458.
[8] Kosar MN, Ongen A, Karakas BR, et al. Xanthogranulomatous cholecystitis: an analysis of 55 cases[J]. Eur Surg, 2014, 46(6):273-276.
[9] Han SH, Chen YL. Diagnosis and treatment of xanthogranulomatous cholecystitis: a report of 39 cases[J]. Cell Biochem Biophys, 2012, 64(2):131-135.
[10] Ghosh M, Sakhuja P, Agarwal AK. Xanthogranulomatous cholecystitis: a premalignant condition?[J]. Hepatobiliary Pancreat Dis Int, 2011, 10(2):179-184.
[11] Yabanoglu H, Aydogan C, Karakayali F, et al. Diagnosis and treatment of xanthogranulomatous cholecystitis[J]. Eur Rev Med Pharmacol Sci, 2014, 18(8):1170-1175.
[12] Nacif LS, Hessheimer AJ, Rodríguez Gómez S, et al. Infiltrative xanthogranulomatous cholecystitis mimicking aggressive gallbladder carcinoma: a diagnostic and therapeutic dilemma[J]. World J Gastroenterol, 2017, 23(48):8671-8678.
[13] Khan MR, Begum S. Extended resection for xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: cases and review of diagnostic approach[J]. J Pak Med Assoc, 2019, 69(2):256-260.
[14] Lee ES, Kim JH, Joo I, et al. Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder carcinoma[J]. Abdom Imaging, 2015, 40(7):2281-2292.
[15] Park JW, Kim KH, Kim SJ, et al. Xanthogranulomatous cholecystitis: is an initial laparoscopic approach feasible?[J]. Surg Endosc, 2017, 31(12):5289-5294.
[16] Goshima S, Chang S, Wang JH, et al. Xanthogranulomatous cholecystitis: diagnostic performance of CT to diffe-rentiate from gallbladder cancer[J]. Eur J Radiol, 2010, 74(3):79-83.
[17] 吴世勇, 胡苗苗, 李梅, 等. 黄色肉芽肿性胆囊炎的多层螺旋CT不典型征象[J]. 中国医学影像学杂志, 2019, 27(7):501-503.
[18] Zhao F, Lu PX, Yan SX, et al. CT and MR features of xanthogranulomatous cholecystitis: an analysis of conse-cutive 49 cases[J]. Eur J Radiol, 2013, 82(9):1391-1397.
[19] Chun KA, Ha HK, Yu ES, et al. Xanthogranulomatous cholecystitis: CT features with emphasis on differentiation from gallbladder carcinoma[J]. Radiology, 1997, 203(1):93-97.
[20] Ogawa T, Horaguchi J, Fujita N, et al. High b-value diffusion-weighted magnetic resonance imaging for gallbladder lesions: differentiation between benignity and malignancy[J]. J Gastroenterol, 2012, 47(12):1352-1360.
[21] Shuto R, Kiyosue H, Komatsu E, et al. CT and MR ima-ging findings of xanthogranulomatous cholecystitis: corre-lation with pathologic findings[J]. Eur Radiol, 2004, 14(3):440-446.
[22] Kang TW, Kim SH, Park HJ, et al. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI[J]. Clin Radiol, 2013, 68(10):992-1001.
[23] Koh T, Tanigichi H, Yamaguchi A, et al. Differential dia-gnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose(FDG-PET)[J]. J Surg Oncol, 2003, 84(2):74-81.
[24] Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma[J]. J Gastrointest Surg, 2004, 8(1):90-97.
[25] 李勇, 李凯琅, 曹葆强. 糖类抗原19-9在三种胆囊良恶性疾病中的表达研究[J]. 安徽医药, 2016, 20(10):1926-1929.
[26] Yu H, Yu TN, Cai XJ. Tumor biomarkers: help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5[J]. Chin Med J, 2013, 126(16):3044-3047.
[27] Suzuki H, Wada S, Araki K, et al. Xanthogranulomatous cholecystitis: difficulty in differentiating from gallbladder cancer[J]. World J Gastroenterol, 2015, 21(35):10166-10173.
[28] 张道建, 张德祥, 王吉文, 等. 超声造影对胆囊癌与黄色肉芽肿性胆囊炎的鉴别诊断价值[J]. 外科理论与实践, 2020, 25(4):322-325.
[29] Hijioka S, Mekky M A, Bhatia V, et al. Can EUS-guided FNA distinguish between gallbladder cancer and xanthogranulomatous cholecystitis?[J]. Gastrointest Endosc, 2010, 72(3):622-627.
[30] Krishnani N, Shukla S, Jain M, et al. Fine needle aspiration cytology in xanthogranulomatous cholecystitis, gallbladder adenocarcinoma and coexistent lesions[J]. Acta Cytol, 2000, 44(4):508-514.
[31] 沈军, 董谦, 杨勇, 等. 黄色肉芽肿性胆囊炎的临床诊断及治疗[J]. 中国普通外科杂志, 2007, 16(2):186-187.
[32] 李镇利, 杨田. 黄色肉芽肿性胆囊炎的诊断和外科治疗[J]. 临床肝胆病杂志, 2017, 33(2):247-252.
[33] Kwon AH, Matsui Y, Uemura Y. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis[J]. J Am Coll Surg, 2004, 199(2):204-210.
[34] 王蔚蓝, 孙海明. 黄色肉芽肿性胆囊炎45例诊治分析[J]. 肝胆胰外科杂志, 2015, 27(1):74-75.
[35] 孙备, 周一男. 腹腔镜胆囊癌根治术的适应证及临床价值[J]. 中国普外基础与临床杂志, 2012, 19(4):364-367.
[36] 张宗明, 张翀, 刘立民, 等. 胆囊癌转移与种植的防治现状[J]. 肿瘤综合治疗电子杂志, 2019, 5(4):28-31.
文章导航

/